Kinetic mechanism of protease inhibition by α1-antitrypsin

被引:14
|
作者
Kang, UB
Baek, JH
Ryu, SH
Kim, J
Yu, MH
Lee, C
机构
[1] Korea Inst Sci & Technol, Ctr Biomed Res, Seoul 130650, South Korea
[2] Korea Inst Sci & Technol, Funct Proteom Ctr, Seoul 130650, South Korea
[3] Korea Univ, Biochem Lab, Sch Life Sci & BIotechnol, Seoul 136701, South Korea
关键词
acyl intermediate; alpha(1)-antitrypsin; rapid-quench study; rate-determining step; salt bridge; serpin; stopped-flow experiment;
D O I
10.1016/j.bbrc.2004.08.105
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The native form of serine protease inhibitor (serpin) is kinetically trapped in a metastable state. Metastability in these proteins is critical to inhibit target protease by forming a stable covalent complex. Despite recent determination of the crystal structures of a Michaelis protease-serpin complex as well as a stable covalent complex, details on the kinetic mechanism remain unsolved. In this report, we examined the reaction mechanism of alpha(1)-antitrypsin toward elastase by a combination of stopped-flow experiments via fluorescence resonance energy transfer and rapid-quench studies. The results suggest a non-covalent complex intermediate other than Michaelis complex as an intermediate before the cleavage of P1-P1' scissile bond, whose formation is the rate-determining step of the overall reaction. This rate-limiting step represents rearrangement of the reactive site loop, and is regulated by a Salt bridge between E354 and R196. The ionic interaction is unique to alpha(1)-antitrypsin, which suggests that protease inhibition mechanisms are varied among serpins. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 50 条
  • [31] Enigma of α1-antitrypsin:: α1-antitrypsin deficiency reveals a puzzling physiological function
    Nukiwa, T
    INTERNAL MEDICINE, 2001, 40 (04) : 271 - 272
  • [32] Mechanism of α1-antitrypsin gene expression in breast carcinoma.
    Ray, BK
    Chatterjee, S
    Ray, A
    FASEB JOURNAL, 1998, 12 (08): : A1344 - A1344
  • [33] Successful α1-antitrypsin replacement therapy in a patient with α1-antitrypsin deficiency and granulomatosis with polyangiitis
    Hernandez Perez, Jose Maria
    Garcia, Sergio Fumero
    Pio, Alberto Alvarez
    RHEUMATOLOGY, 2013, 52 (04) : 755 - 757
  • [34] Characterization of the monomers of the accumulation of the Z mutation α1-Antitrypsin associated with α1-antitrypsin deficiency
    Marker, Amanda
    Long, Olivia
    Fisher, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [35] Panniculitis in α1-Antitrypsin Deficiency
    Xu, Kathryn K.
    Proffer, Sydney L.
    Wieland, Carilyn
    MAYO CLINIC PROCEEDINGS, 2024, 99 (08) : 1210 - 1211
  • [36] Inhibition of Human Neutrophil Elastase by α1-Antitrypsin Functionalized Colloidal Microcarriers
    Reibetanz, Uta
    Schoenberg, Maria
    Rathmann, Sophie
    Strehlow, Vincent
    Goese, Martin
    Lessig, Jacqueline
    ACS NANO, 2012, 6 (07) : 6325 - 6336
  • [37] Inhibition of proteinase 3 by α1-antitrypsin in vitro predicts very fast inhibition in vivo
    Duranton, M
    Bieth, JG
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 29 (01) : 57 - 61
  • [38] α1-antitrypsin deficiency and inflammation
    Ekeowa, Ugo I.
    Marciniak, Stefan J.
    Lomas, David A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (02) : 243 - 252
  • [39] α1-antitrypsin: a polyfunctional protein?
    Stockley, Robert A.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (05): : 341 - 343
  • [40] Alpha 1-antitrypsin deficiency
    Faehndrich, Sebastian
    Bals, Robert
    INNERE MEDIZIN, 2024, : 533 - 537